Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES |
|
![](http://www.worldpharmatoday.com/images/article/Weekly_newsletter/comman_images/6.png) |
Latest News & Press Releases |
|
|
Moderna and Catalent Announce Collaboration for Dedicated Vial Filling of COVID-19 Vaccine and Clinical Portfolio.
Moderna and Catalent announced the expansion of their strategic collaboration to dedicate a new high-speed vial filling line for the manufacture...
|
|
![](https://www.worldpharmatoday.com/images/nBanners/KO_LOGO.jpg )
|
|
| | |
| |
|
|
|
FedEx Distribution of COVID-19 Vaccines Grows, Reaches 100 Million Vaccine Doses Delivered.
FedEx has been on the frontlines of the COVID-19 pandemic, delivering pharmaceuticals, personal protective equipment, critical medical supplies...
|
|
| | | | |
| |
|
AB Science and University of Chicago to develop Covid-19 drugs.
AB Science SA and University of Chicago, announces the signing of an exclusive licensing agreement for conducting research on the prevention and treatment...
|
|
![](https://www.worldpharmatoday.com/wp-content/uploads/news/17700/ab-science-324x235.jpg)
|
|
|
|
|
Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover.
Novavax announced the initiation of crossover arms in two ongoing clinical trials of NVX-CoV2373, the company's COVID-19 vaccine candidate.
|
|
|
| |
|
Sound Pharmaceuticals to launch NIH-funded Covid-19 oral therapeutic trial.
Developed for various neurotologic, neuropsychiatric, and respiratory indications, SPI-1005 is a capsule with a small molecule called ebselen....
|
|
![](https://www.worldpharmatoday.com/wp-content/uploads/news/15672/Covid-19-vaccines-clinical-324x235.jpg) |
|
| | |
|
| |
|
|
|
Sanofi to build new facility in Canada to increase global availability of high-dose influenza vaccine.
Sanofi announced an investment of more than €600 million in a new vaccine manufacturing facility at its existing site in Toronto, Canada. ...
|
|
|
| |
|
Oxford Pauses Dosing in Trial of AstraZeneca Covid-19 Vaccine in Children, Teenagers.
The University of Oxford said that it had paused a small UK trial testing the COVID-19 vaccine it developed with AstraZeneca in children and teenagers...
|
|
![](https://www.worldpharmatoday.com/wp-content/uploads/news/17697/Vaccine_Stoped-324x235.jpg) |
|
|